The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Magnesium Sulfate in Dextrose
Magnesium Sulfate in Dextrose · MAGNESIUM SULFATE HEPTAHYDRATE 10 mg/mL · Injection, Solution · Intravenous · Hospira, Inc.
NDC 00409-6727-23 · 24 POUCH in 1 CASE / 1 BAG in 1 POUCH / 100 mL in 1 BAG · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$197.29
Reported to Texas DSHS · 2026 annual filing · Pfizer Inc.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Medicare Part B (ASP)
Payment limit per 500 MG
$0.446
HCPCS J3475 · Jul 1, 2026 quarter · typically ASP + 6%
Medicaid spend (2025)
$22,274
2,562 prescriptions paid by Medicaid nationally · all Medicaid spend →
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- Alcami Carolinas CorporationUnited Statesanalysis
- Hospira, Inc.United Statesanalysis · label · manufacture · pack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 2 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program · Xywav and Xyrem
Regulatory
- Application
- NDA020488
- TE code
- AP
- Approval date
- Jul 11, 1995
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
- Class I · TerminatedMar 6, 2015Hospira Inc. — Labeling: Wrong Bar Code: There is a potential for some units to be mislabeled with an incorrect barcode on the immediate container that scans as heparin sodium 2000 USP units/1000 mL in 0.9% in sodium chloride injection.
Manufacturers of Magnesium Sulfate in Dextrose (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Baxter Healthcare Corporation | MAGNESIUM SULFATE HEPTAHYDRATE 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Hospira, Inc. | MAGNESIUM SULFATE HEPTAHYDRATE 10 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Magnesium Sulfate in Dextrose — NDC 00409-6727-23," retrieved September 3, 2026, https://drugdashboards.com/drug/00409672723.
Free to cite with attribution — see how the data is put together.